key: cord-0777346-xmswflxj
authors: Olivares, Alberto; Staffetti, Ernesto
title: Optimal Control-Based Vaccination and Testing Strategies for COVID-19
date: 2021-09-21
journal: Comput Methods Programs Biomed
DOI: 10.1016/j.cmpb.2021.106411
sha: 87748a621e2be4080f86c55f259c81678bf2713c
doc_id: 777346
cord_uid: xmswflxj

Background and Objective:Assuming the availability of a limited amount of effective COVID-19 rapid tests, the effects of various vaccination strategies on SARS-CoV-2 virus transmission are compared for different vaccination scenarios characterized by distinct limitations associated with vaccine supply and administration. Methods:The vaccination strategies are defined by solving optimal control problems of a compartmental epidemic model in which the daily vaccination rate and the daily testing rate for the identification and isolation of asymptomatic subjects are the control variables. Different kinds of algebraic constraints are considered, representing different vaccination scenarios in which the total amount of vaccines available during the time period under consideration is limited or the number of daily available vaccines is limited. These optimal control problems are numerically solved by means of a direct transcription technique, which allows both equality and inequality constraints to be straightforwardly included in the formulation of the optimal control problems. Results:Several numerical experiments are conducted, in which the objective functional to be minimized is a combination of the number of symptomatic and asymptomatic infectious subjects with the cost of vaccination of susceptible subjects and testing of asymptomatic infectious subjects. The results confirm the hypothesis that the implementation of early control measures significantly reduces the number of symptomatic infected subjects, which is a key aspect for the resilience of the healthcare system. The sensitivity analysis of the solutions to the weighting parameters of the objective functional reveals that it is possible to obtain a vaccination strategy that allows vaccination supplies to be saved while keeping the same number of symptomatic infected subjects. Furthermore, it indicates that if the vaccination plan is not supported by a sufficient rate of testing, the number of symptomatic infected subjects could increase. Finally, the sensitivity analysis shows that a significant reduction in the efficacy of the vaccines could also lead to a relevant increase in the number of symptomatic infected subjects. Conclusions:The numerical experiments show that the proposed approach, which is based on optimal control of compartmental epidemic models, provides healthcare systems with a suitable method for scheduling vaccination plans and testing policies to control the spread of the SARS-CoV-2 virus.

the hypothesis that the implementation of early control measures significantly reduces the number of symptomatic infected subjects, which is a key aspect for the resilience of the healthcare system. The sensitivity analysis of the solutions to the weighting parameters of the objective functional reveals that it is possible to obtain a vaccination strategy that allows vaccination supplies to be saved while keeping the same number of symptomatic infected subjects. Furthermore, it indicates that if the vaccination plan is not supported by a sufficient rate of testing, the number of symptomatic infected subjects could increase. Finally, the sensitivity analysis shows that a significant reduction in the efficacy of the vaccines could also lead to a relevant increase in the number of symptomatic infected subjects.

The numerical experiments show that the proposed approach, which is based on optimal control of compartmental epidemic models, provides healthcare systems with a suitable method for scheduling vaccination plans and testing policies to control the spread of the SARS-CoV-2 virus.

Transmission Dynamics, Epidemic Compartmental Model, Sensitivity Analysis

The problem of determining the most effective strategy for controlling the spread of an epidemic disease like COVID-19 can be formulated as an Optimal Control Problem (OCP), in which the goal is to minimize, over a time period, an objective functional typically associated with the cost of the control measures or the number of infectious subjects, in the presence of dynamic constraints, which represent the dynamic system that models the disease transmission, and algebraic constraints, such as limitations on the vaccination and testing supplies. This paper considers an objective functional that combines the number of symptomatic and asymptomatic infected subjects with the cost of vaccination of susceptible subjects and testing of asymptomatic infectious subjects. Moreover, different scenarios are studied, which are represented by different algebraic con-straints in the OCP, in which the total amount of vaccines available during the time period under consideration is limited or the number of daily available vaccines is limited. The disease transmission and its interaction with these control measures are modeled using a compartmental epidemic model.

Optimal control is a research field with many applications in biology [1] and biomedicine [2] . More specifically, it has been widely used to investigate compartmental models in epidemiology. The following relevant related research works are highlighted. In [3] , a time-optimal control problem is formulated, in which different control policies such as vaccination, isolation, culling, and reduction of transmission, have been considered. In [4] , a spatiotemporal epidemic model is formulated as a system of parabolic partial differential equations with no-flux boundary conditions, where immunity is forced through vaccine distribution, which is considered the control variable. A Bernstein-Bézier parametrization and an echo state networks-based algorithm are proposed in [5] to solve an OCP with two control variables of the epidemic model. In [6] , an optimal impulse control approach is used to solve an isolation problem for an epidemic model describing the transmission of HIV. In [7] , optimal coverage strategies are derived for an epidemic model consisting of two groups of hosts under the assumption of a resource-constrained environment. A vaccination strategy for influenza outbreaks is obtained in [8] using a reaction-diffusion model. In [9] , five different control strategies are presented for curtailing dengue fever spread.

Non-pharmaceutical measures like public health education, isolation, and quarantine are investigated in [10] as time-dependent interventions to determine their contributions to COVID-19 transmission dynamics. In [11] , real data from China are used to formulate an optimal control strategy for vaccine administration in COVID-19 pandemic treatment. A COVID-19 disease spread model with free terminal optimal time is described in [12] , in which the aim is to reduce the size of susceptible, infected, exposed, and asymptomatic groups to eliminate the infection through quarantine and treatment of infected subjects.

As mentioned above, this paper considers the problem of determining and comparing optimal vaccination and testing strategies for a compartmental model of the COVID-19 transmission dynamics derived from the epidemic model introduced in [13] . More specifically, it analyzes and compares the effects of different vaccination and testing strategies on the disease transmission based on the definition of different scenarios that are modeled as OCPs with different kinds of algebraic constraints. These OCPs are numerically solved by means of a direct transcription technique, which allows both equality and inequality constraints to be included in their formulation in a straightforward manner. In particular, the Hermite-Simpson collocation method [14] is used. The NLP solver IPOPT [15] is employed to solve the Non Linear Programming (NLP) problems derived from the transcription of these OCPs. The numerical experiments show that the proposed approach provides healthcare systems with a suitable method for scheduling vaccination plans and testing policies to control the spread of the SARS-CoV-2 virus. 

A modified SEIR compartmental model, introduced in [13] and denoted as SEIsIaQR, is used in this paper to represent the COVID-19 transmission dynamics, in which, following [16] , a vaccination term is added to the model as shown in Figure 1 .

The state space representation of the SEIsIaQR model is given by the following system of Ordinary Differential Equations (ODE):

in which N (t) and the variables with time derivative are the state variables of the system. More specifically, S(t) denotes the number of subjects susceptible to infection, E(t) denotes the number of exposed subjects, I s (t) denotes the number of symptomatic subjects, I a (t) denotes the number of asymptomatic subjects, Q(t) denotes the number of isolated subjects, R(t) denotes the number of recovered and deceased subjects, and N (t) denotes the total population, which satisfies the condition

The control variables of the system (1) are v(t) and κ a (t). The control

variable v(t) represents the daily vaccination rate, which ranges from 0 to v U ,

where v U is an upper bound that the designers of the OCP must specify. Thus, v(t)S(t) represents the vaccination strategy in system (1). The control variable κ a (t) represents the daily testing rate for the identification and isolation of asymptomatic subjects, which ranges from 0 to κ U , where κ U is an upper bound that the designers of the OCP must also specify.

The parameters θ and κ S of the system (1) are associated with the use of non-pharmacological containment strategies, where θ denotes the replication factor and κ s denotes the daily testing rate for the identification and isolation of symptomatic subjects. The parameters T ser , T lat , T inf , α, and β of the system (1) do not depend on containment or mitigation strategies, where T ser is the mean serial time interval, T lat is the mean incubation period, T inf = T ser − T lat is the infectious period, α is the ratio between the infectiousness of asymptomatic and symptomatic subjects, and β is the population ratio that remains asymptomatic or mild symptomatic. The values for all these parameters used in the numerical experiments are the same as in [16] .

In this paper, following [16] , a vaccination term is included in the model proposed in [13] and several OCPs are formulated considering different kinds of algebraic constraints, in which both the daily vaccination rate v(t) and the daily testing rate for the identification and isolation of asymptomatic subjects κ a (t) are assumed to be the control variables.

Depending on the scenario and the objective functional considered, it is possible to determine different vaccination and testing strategies for controlling the spread of COVID-19 represented by the model (1). In this paper, three different scenarios have been considered, in which vaccination supplies are limited:

• Scenario 1, in which the number of vaccines administered during the time

• Scenario 2, in which there is an upper bound on the number of vaccines administered during the time period [t I , t F ].

• Scenario 3, in which there is an upper bound on the number of vaccines administered each day.

They correspond to three different kinds of constraints, namely an isoperimetric constraint, a state constraint, and a mixed state-control constraint, respectively.

In all three cases, the objective functional to be minimized has been assumed to be a combination of the number of symptomatic and asymptomatic infectious subjects with the overall cost of the vaccination of susceptible subjects and the testing of asymptomatic infectious subjects during a fixed time period, that is,

where A i ∈ [0, 1], i = 1, 2, 3, 4, are weighting parameters that the designers of the OCP must specify according to their preferences. For instance, larger values of A 3 give more importance to the vaccination cost.

In this scenario, it is assumed that the number of vaccines available during the time period [t I , t F ] is known and that they are all administered. Thus, the number of vaccines administered during the time period [t I , t F ] is fixed and, according to [17] , this condition can be modeled by the following isoperimetric

where V T denotes the total number of susceptible people that are vaccinated over the time period [t I , t F ]. The integral constraint (3) can be tackled by defining a new state variable W (t) and a new differential equation together with its corresponding boundary conditions, as follows:

In this scenario, unlike Scenario 1, in which it is assumed that the number of vaccines available in the time period [t I , t F ] is known and they are used completely, it is assumed that they can either be administered completely or not.

While the isoperimetric constraint (3) assumes that all the vaccines available are used, according to [18] , this condition can be easily relaxed by considering the inequality constraint

instead of W (t F ) = V T , which represents an overall upper bound on the supply of vaccines over the time period [t I , t F ]. Notice that the inequality constraint

In this scenario, it is assumed that the daily number of vaccines available during the time period [t I , t F ] is known and that they can either be used completely or not. This condition, according to [18] , can be modeled replacing the

where the parameter V 0 denotes an upper bound on the number of daily vaccinated susceptible people. Notice that the expression (5) is a mixed state-control constraint.

Thus, the OCP of the SEIsIaQR compartmental model (1) with mixed state-control constraint can be stated as follows:

subject to:

where J(I s (t), I a (t), v(t), κ a (t)) is defined as in (2),

Notice that similar OCPs can be formulated using isoperimetric and state constraints.

The OCP formulated in (6) is a particular case of a more general OCP of the form:

subject to:

in which t represents time, with t I and t F denoting the initial and final times, Notice that the Lagrange term in the objective functional (7a) can be converted to a Mayer term by adding a new state variable, x M (t), and a new differential equation together with the corresponding initial condition, namely:

Then, the expression x M (t F ) can be used in place of the Lagrange term.

The Hermite-Simpson direct collocation method [19] is used in this paper to transform the OCP formulated in (7) into a NLP problem. This method is a particular case of a family of direct transcription methods known as Hermite-Legendre-Gauss-Lobatto methods [20] . Following [14] , the time period [t I , t F ] is subdivided into N subintervals of equal length ∆t, the endpoints of which are

Hermite-Simpson numerical integration scheme is employed. The obtained NLP problem, which is solved using the open source IPOPT solver [15] , consists of the Hermite-Simpson system constraints associated with the differential constraint (7b) and the discretized form of the the algebraic constraints (7c) and the boundary conditions (7d).

In order to illustrate the application of the proposed approach to determine the optimal vaccination and testing strategies to control SARS-CoV-2 virus transmission using the SEIsIaQR compartmental model (1) Additionally, 95% vaccine efficacy is assumed with an upper bound v U = 0.0035 on the daily vaccination rate. It is also assumed that two doses of vaccine are required to develop immunity and an upper bound κ U = 0.25 on the daily identification and isolation rate of asymptomatic subjects is considered.

Moreover, these numerical experiments are solved assuming mild containment measures and the identification and isolation of the majority of infected symptomatic subjects. In particular, according to [13] , the replication factor is set to θ = 3 and the daily testing rate for identification and isolation of symptomatic subjects is set to κ s = 0.95.

This section, the optimal vaccination and testing strategies obtained by solving the OCP for the SEIsIaQR compartmental model defined in (1) for scenarios 1, 2, and 3 defined in Section 2.2 with different values of the weighting parameters will be examinated. In all these OCPs, 95% vaccine efficacy has been assumed and the weighting parameters have been set to A 1 = 1, A 2 = 0.1, A 3 = 0.5, and A 4 = 0.0025.

For the sake of comparison, the optimal vaccination and testing strategies for In the optimal vaccination strategy obtained for Scenario 3, the scheduled daily vaccination rate grows progressively during the first 100 days, until it reaches its upper bound. After maintaining the maximum value for 40 days, it decreases at a high rate until it reaches zero at the end of the considered time period. In the optimal vaccination strategy for scenarios 1 and 2, a bang-bang control is obtained, in which the maximum daily vaccination rate is scheduled during the first 100 days until the vaccination supplies run out. These different optimal vaccination strategies yield significant differences in the state variables as shown in Figure 3 . The optimal vaccination strategy for Scenario 3 results in higher peaks for the proportions of subjects in compartments E, I s , I a , and Q. For instance, in the worst case, the percentage of symptomatic subjects in a single day is 0.0406% in scenarios 1 and 2, whereas this percentage rises to 0.0626% in Scenario 3. While the percentage in the first case could be handled by a sufficiently resilient healthcare system, it could place considerable stress on the healthcare system in the second case. Moreover, the percentage of immunized subjects at the end of this time period would be 58.57% in scenarios 1 and 2 and 67.15% in Scenario 3. This last percentage would be close to the estimated threshold for achieving herd immunity [21] .

Notice that, as mentioned above, in all three scenarios, 22% of the susceptible subjects would become immune through vaccination in six months. 

In this section, the optimal vaccination strategies obtained by solving the OCP for the SEIsIaQR compartmental model defined in (1) for Scenario 3 defined in Section 2.2 with different values of the weighting parameters will be examined to analyze the sensitivity of the optimal vaccination and testing strategies to the weighting parameters of the objective functional (2) . In all these OCPs, 95% vaccine efficacy has been assumed and different values for the weighting parameters have been considered. Figure 4 shows the optimal daily vaccination rate v(t), the optimal daily testing rate for the identification and isolation of asymptomatic subjects κ a , and the corresponding proportions of symptomatic subjects I s and recovered subjects R obtained in three solutions of the OCP computed assuming three different values of the parameter A 1 , namely 0.01, 0.1, and 1, keeping the other parameters A 2 = 0.1, A 3 = 0.5, and A 4 = 0.0025 fixed. It can be seen that variations in the parameter A 1 result in solutions that exhibit slight changes in the optimal daily vaccination rate, the optimal daily testing rate, and the corresponding proportion of symptomatic subjects, while the proportion of recovered subjects remains almost the same. Figure 5 : Optimal daily vaccination rate v(t), optimal daily testing rate κa(t), proportion of symptomatic subjects Is(t), and proportion of recovered subjects R(t) obtained assuming that A 2 = 0.001 (orange), A 2 = 0.1 (blue), A 2 = 1 (green), keeping parameters A 1 = 1, A 3 = 0.5, and A 4 = 0.0025 fixed. Figure 5 shows the optimal daily vaccination rate v(t), the optimal daily testing rate for the identification and isolation of asymptomatic subjects κ a , and the corresponding proportions of symptomatic subjects I s and recovered subjects R obtained in three solutions of the OCP computed assuming three different values of the parameter A 2 , namely 0.001, 0.1, and 1, keeping the other parameters A 1 = 1, A 3 = 0.5, and A 4 = 0.0025 fixed. It can be seen that there are significant differences in the daily testing rate obtained in the solutions.

More specifically, the greater the value of A 2 , the longer the optimal daily testing rate keeps its maximum value. Moreover, variations in the parameter A 2 result in solutions that exhibit slight changes in the optimal vaccination rate and the corresponding proportion of symptomatic subjects, while the proportion of recovered subjects remains almost the same. 

Recovered, R Figure 6 : Optimal daily vaccination rate v(t), optimal daily testing κa(t), proportion of symptomatic subjects Is(t), and proportion of recovered subjects R(t) obtained assuming that A 3 = 0.5 (green), A 3 = 5 (blue), A 3 = 10 (orange), keeping parameters A 1 = 1, A 2 = 0.1, and A 4 = 0.0025 fixed. Figure 6 shows the optimal daily vaccination rate v(t), the optimal testing rate for the identification and isolation of asymptomatic subjects κ a , and the corresponding proportions of symptomatic subjects I s and recovered subjects R obtained in three solutions of the OCP computed assuming three different values of the parameter A 3 , namely 0.5, 5, and 10, keeping the other parameters A 1 = 1, A 2 = 0.1, and A 4 = 0.0025 fixed. It can be seen that there are significant differences in the optimal daily vaccination rates obtained in the solutions. Moreover, variations in the parameter A 3 result in solutions that exhibit slight changes in the optimal daily testing rate and the corresponding proportion of recovered subjects, while the proportion of symptomatic subjects remains almost the same. Therefore, from the perspective of the resilience of the healthcare system, the same result would be obtained following the vaccination strategies represented in orange and green, with the difference that the former requires 5.89% less vaccination supplies than the latter. Figure 7 shows the optimal daily vaccination rate v(t), the optimal daily testing rate for the identification and isolation of asymptomatic subjects κ a , and the corresponding proportions of symptomatic subjects I s and recovered subjects R obtained in three solutions of the OCP computed assuming three different values of the parameter A 4 , namely 0.0025, 0.005, and 0.01, keeping the other parameters A 1 = 1, A 2 = 0.1, and A 3 = 0.5 fixed. It can be seen that there are significant differences in all the control and state variables obtained in the optimal solution when the value A 4 = 0.01 is considered. Therefore, it can be deduced that there is a threshold for the weighting parameter A 4 above which the optimal daily vaccination and testing rates change significantly, and the corresponding proportion of symptomatic subjects increases dramatically.

In this section, the optimal vaccination strategies obtained by solving the OCP for the SEIsIaQR compartmental model defined in (1) for Scenario 3 de-fined in Section 2.2 with different levels of vaccine efficacy will be examined to analyze the sensitivity of the optimal vaccination and testing strategies to the vaccine efficacy. In these OCPs, three different levels of vaccine efficacy have been considered, namely 50%, 75%, and 95%. Figure 8 : Optimal daily vaccination rate v(t), optimal daily testing rate κa(t), proportion of symptomatic subjects Is(t), and proportion of recovered subjects R(t) obtained assuming A 1 = 1, A 2 = 0.1, A 3 = 0.5, and A 4 = 0.0025, and levels of vaccine efficacy 50% (orange), 75% (blue), and 95% (green). Figure 8 shows the optimal daily vaccination rate v(t), the optimal daily testing rate for the identification and isolation of asymptomatic subjects κ a , and the corresponding proportions of symptomatic subjects I s and recovered subjects R obtained in the solutions of the three OCPs computed assuming that A 1 = 1, A 2 = 0.1, A 3 = 0.5, and A 4 = 0.0025. It can be seen that variations in the vaccine efficacy result in solutions that exhibit slight changes in the optimal daily vaccination rate, the optimal daily testing rate, and the corresponding proportion of recovered subjects, while the proportion of symptomatic subjects changes significantly. Therefore, since the optimal vaccination strategy barely changes, a decrease in the level of vaccine efficacy implies an increase in the proportion of symptomatic subjects that could imply an overwhelmed healthcare system.

In this paper, several vaccination and testing strategies for the control of the SARS-CoV-2 virus transmission for three different vaccination scenarios characterized by different constraints associated with vaccine availability and administration have been proposed and their effects on the disease transmission have been compared. The results of the numerical experiments show that identical vaccination strategies are obtained for Scenario 1, in which the total number of vaccines used is fixed at a certain value, and Scenario 2, in which the total number of vaccines used is upper-bounded at the same value. Moreover, the optimal vaccination strategies for scenarios 1 and 2 confirm the hypothesis that the implementation of early control measures significantly reduces the number of symptomatic infected subjects, which is a key aspect for the resilience of the healthcare system. The optimal vaccination strategy obtained in Scenario 3 differs significantly from the optimal vaccination strategies obtained for the other scenarios, whereas the optimal testing strategies for identification and isolation of asymptomatic subjects obtained for the three scenarios are similar. Scenario 3 would be compatible with a vaccination program in which the availability of vaccines would gradually increase. The sensitivity analysis of the solutions to the weighting parameters of the objective functional reveals that it is possible to obtain a vaccination strategy that allows almost 6% of vaccination supplies to be saved while keeping the same number of symptomatic infected subjects.

Furthermore, it indicates that if the vaccination plan is not supported by a sufficient rate of testing, the number of symptomatic infected subjects could increase considerably. Similarly, the sensitivity analysis of the solutions to vaccine efficacy shows that a significant reduction in the efficacy of the vaccines could also lead to a relevant increase in the number of symptomatic infected subjects.

The authors state that ethical approval is not required for this type of study in the country where the study was conducted.

Time-optimal control strategies in SIR epidemic models

An optimal control problem for a spatiotemporal SIR model

Bézier curve parametrisation and echo state network methods for solving optimal control problems of SIR model

Optimal impulse control of a SIR epidemic

Optimal control strategies for a two-group epidemic model with vaccination-resource constraints

Optimal control problem of an SIR reactiondiffusion model with inequality constraints

Optimal control strategies for dengue fever

Controlling the spread of COVID-19: Optimal control analysis

Determination of an optimal control strategy for vaccine administration in COVID-19 pandemic treatment

Optimal control design of impulsive SQEIAR epidemic models with application to COVID-19

Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies

Direct optimization using collocation based on high-order Gauss-Lobatto quadrature rules

On the implementation of an interior-point filter line-search algorithm for large-scale nonlinear programming

Uncertainty quantification of a mathematical model of COVID-19 transmission dynamics with mass vaccination strategy

An introduction to optimal control with an application in disease modeling

A SEIR model for control of infectious diseases with constraints

Direct trajectory optimization using nonlinear programming and collocation

Direct and indirect methods for trajectory optimization

COVID-19 herd immunity: where are we?

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.